True Wealth Design’s iTeos Therapeutics ITOS Stock Holding History

True Wealth Design’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-125	Closed	-$1.25K	–	2804
2025 Q2	$1.25K	Sell	125 -40	-24%	-$322	﹤0.01%	1377
2025 Q1	$986	Buy	165 +120	+267%	+$881	﹤0.01%	1271
2024 Q4	$346	Buy	+45	New	+$387	﹤0.01%	1151

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

True Wealth Design's ITOS Position: Q3 2025 in Review

True Wealth Design sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 125 shares — an estimated $1.25K sold.

True Wealth Design first reported a position in ITOS in Q4 2024 and held it in 3 quarters. The position peaked at $1.25K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

True Wealth Design reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
True Wealth Design sold 125 iTeos Therapeutics shares in Q3 2025, an estimated $1.25K.
True Wealth Design first reported a position in iTeos Therapeutics in Q4 2024 and held it in 3 quarters.
True Wealth Design's iTeos Therapeutics position peaked at $1.25K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on True Wealth Design's 13F filing for Q3 2025, filed 21 Oct 2025.